Upgrade to SI Premium - Free Trial

CRISPR Therapeutics (CRSP) PT Raised to $100 at Roth Capital

November 19, 2019 11:50 AM
Roth Capital analyst Tony Butler ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles